Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Beijing Sungen Biomedical Technology Co., Ltd

Clinical trials sponsored by Beijing Sungen Biomedical Technology Co., Ltd, explained in plain language.

Trials to join now! 1 Completed 2

New injection could shrink heart attack scarring

Disease control Recruiting now

This study tests a new medicine called SGC001 in 210 people having a heart attack (anterior STEMI) and scheduled for a procedure to open blocked arteries (pPCI). The drug aims to reduce heart muscle damage and inflammation, potentially preventing future heart problems. Participan…

Phase: PHASE2 • Sponsor: Beijing Sungen Biomedical Technology Co., Ltd • Aim: Disease control

Last updated May 26, 2026 12:12 UTC